NCT01759849 Effect of in Vitro Blocking the Common Beta Chain on Cell Viability in Asthma Status COMPLETED Phase N/A
NCT01632852 A Study of CSL362 in Patients With CD123+ Acute Myeloid Leukemia Currently in Remission Status COMPLETED Phase PHASE1
NCT01499420 A Single Ascending Dose Study Examining the Safety and Pharmacokinetic Profile of Reconstituted High Density Lipoprotein (CSL112) Administered to Patients Status COMPLETED Phase PHASE2
NCT01281774 A Multiple Ascending Dose Study of CSL112 in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT01129661 Safety, Tolerability and Pharmacokinetics of CSL112 in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT00680446 Safety Study of Subcutaneous Ig NextGen 16% in Patients With Primary Immunodeficiency Status COMPLETED Phase PHASE3
NCT00405184 Ig NextGen 10% in Patients With Primary Immune Deficiency (PID) Status COMPLETED Phase PHASE3
NCT00401739 Safety, Tolerability and Pharmacokinetics of CSL360 in the Treatment of Acute Myeloid Leukemia Status COMPLETED Phase PHASE1
NCT00362349 Ig NextGen 10% in Idiopathic Thrombocytopenic Purpura (ITP) Patients Status COMPLETED Phase PHASE3
NCT00225719 Effect of rHDL on Atherosclerosis - Safety and Efficacy: THE ERASE TRIAL Status COMPLETED Phase PHASE2